Lead Faculty, Cancer Immunotherapy & Adoptive Cell Therapy at University of California, Irvine in Orange, California

Job Description:

POSITION OVERVIEW
Salary range: The compensation range for this position for faculty in Hematology/Oncology or other appropriate clinical subspecialties is based on AAMC benchmarks ranging from $300,000 to $500,000. The posted UC salary scales set the base pay determined by rank and/or step at appointment and actual compensation will be adjusted for experience training, hospital/community needs and other factors. This position includes membership in the health sciences compensation plan which provides for eligibility for additional compensation.
APPLICATION WINDOW
Open date: March 12, 2024
Next review date: Monday, Apr 15, 2024 at 11:59pm (Pacific Time)
Apply by this date to ensure full consideration by the committee.
Final date: Tuesday, Mar 11, 2025 at 11:59pm (Pacific Time)
Applications will continue to be accepted until this date, but those received after the review date will only be considered if the position has not yet been filled.
POSITION DESCRIPTION
The Hematology/Oncology Division of the Department of Medicine at the University of California, Irvine (UCI) is seeking candidates for a senior physician/scientist tenure-track faculty member position with experience and expertise in the development of immunotherapy of cancer within the broad topic of adoptive cellular therapy (e.g., antigen discovery, CARs, resistance mechanisms, tumor microenvironment as it impacts immunotherapy). This position is at the level of Associate or full Professor, depending upon the candidate's qualifications, experience, and achievements. The successful candidate will be charged with the development, growth, and leadership of a research program in the broad area of adoptive cellular immunotherapy that can be integrated with our expanding, FACT-accredited hematopoietic stem cell transplant (HSCT) program and will be expected to engage in translational and clinical research, clinical education, and potentially limited patient care.
The environment and infrastructure at UCI and UCI Health are ideal for fostering the growth of a cancer adoptive cell therapy (ACT) program. UCI is home to the Chao Family Comprehensive Cancer Center (CFCCC), one of 55 NCI-designated comprehensive cancer centers, and is one of only 23 institutions also holding an NCATS-funded Clinical Translational Science Award. In addition to the UCI Medical Center located in Orange, a new $1.3 billion medical center is under construction on the UCI Irvine campus that will include a new 220,000 sq. ft. outpatient cancer center and a 144 bed specialty hospital that will be the new home of the HSCT and ACT programs. Additional facilities include a newly opened seven room cGMP cellular production facility. It is anticipated that the ACT program will engage with investigators in the CIRM-funded Sue & Bill Gross Stem Cell Institute, the UCI Institute for Immunology, the CFCCC, and the clinical investigators of UCI Health.
To Apply: https://recruit.ap.uci.edu/analyst/recruitments/JPF08304)
QUALIFICATIONS
Basic qualifications (required at time of application)
Competitive candidates are expected to have a defined research focus, a strong record of extramural research funding, strong scholarly track record, and other accomplishments. Applicants must hold an M.D., PhD, or equivalent degree. Holding a PhD or equivalent in addition to the MD or equivalent is preferred but not essential. A successful physician scientist candidate should hold subspecialty certification in an oncologic subspecialty including but not limited to; gynecologic oncology, hematology, medical oncology, or surgical oncology and must possess or be eligible to obtain an active medical practice license in the State of California. Candidates are expected to lead and conduct research within their specific area of focus, with some clinical/translational component.
APPLICATION REQUIREMENTS
Document requirements
* Curriculum Vitae - Your most recently updated C.V.
* Cover Letter
* Statement of Research
* Teaching Statement - See our guidance for writing a reflective teaching statement.
* Inclusive Excellence Activities Statement - Statement addressing how past and/or potential contributions to inclusive excellence will advance UCI's Commitment to Inclusive Excellence. See our guidance for writing an inclusive excellence activities statement.
* Sexual Misconduct, Harassment and Discrimination Declaration Form - All applicants of academic positions at the University of California, Irvine must download, complete, sign, and upload the following form with their application: Sexual Misconduct, Harassment and Discrimination Declaration Form
* Misc / Additional (Optional)
Reference requirements
* 5-7 required (contact information only)
Apply link: https://recruit.ap.uci.edu/JPF08304
ABOUT UC IRVINE
The University of California, Irvine is an Equal Opportunity/Affirmative Action Employer advancing inclusive excellence. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age, protected veteran status, or other protected categories covered by the UC nondiscrimination policy.
As a University employee, you will be required to comply with all applicable University policies and/or collective bargaining agreements, as may be amended from time to time. Federal, state, or local government directives may impose additional requirements.
JOB LOCATION
Irvine-Orange
Lead faculty, cancer immunotherapy & adoptive cell therapy (Division of Hematology/Oncology, Department of Medicine, School of Medicine)

Competitive candidates are expected to have a defined research focus, a strong record of extramural research funding, strong scholarly track record, and other accomplishments. Applicants must hold an M.D., PhD, or equivalent degree. Holding a PhD or equivalent in addition to the MD or equivalent is preferred but not essential. A successful physician scientist candidate should hold subspecialty certification in an oncologic subspecialty including but not limited to; gynecologic oncology, hematology, medical oncology, or surgical oncology and must possess or be eligible to obtain an active medical practice license in the State of California. Candidates are expected to lead and conduct research within their specific area of focus, with some clinical/translational component.